MSLN and lung adenocarcinoma: The overexpression of mesothelin is associated with particularly poor prognosis for patients with lung adenocarcinoma harbouring mutations in the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) gene [29, 30].